Mittal Medicos Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 18-07-2024
- Paid Up Capital ₹ 9.89 M
as on 18-07-2024
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.29 Cr
as on 18-07-2024
- Satisfied Charges ₹ 6.00 M
as on 18-07-2024
- Revenue 98.73%
(FY 2023)
- Profit 139.15%
(FY 2023)
- Ebitda 70.07%
(FY 2023)
- Net Worth 4.73%
(FY 2023)
- Total Assets 14.11%
(FY 2023)
About Mittal Medicos
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 9.89 M.
The company currently has active open charges totaling ₹5.29 Cr. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kamini Gupta and Hitabhilashi Gupta serve as directors at the Company.
- CIN/LLPIN
U24246DL2002PTC115765
- Company No.
115765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Mittal Medicos Private Limited offer?
Mittal Medicos Private Limited offers a wide range of products and services, including Paracetamol Tablets, Crocin Advance Tablet, Crocin Tablets.
Who are the key members and board of directors at Mittal Medicos?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamini Gupta  | Director | 11-Jun-2002 | Current |
| Hitabhilashi Gupta | Director | 11-Jun-2002 | Current |
Financial Performance of Mittal Medicos.
Mittal Medicos Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.73% increase. The company also saw a substantial improvement in profitability, with a 139.15% increase in profit. The company's net worth moved up by a moderate rise of 4.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mittal Medicos?
In 2023, Mittal Medicos had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unimak Biotech Private LimitedActive 3 years 10 monthsKamini Gupta and Hitabhilashi Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 May 2023 | ₹3.69 Cr | Open |
Canara Bank Creation Date: 28 Dec 2022 | ₹1.60 Cr | Open |
Bank Of Baroda Creation Date: 01 Oct 2015 | ₹6.00 M | Satisfied |
How Many Employees Work at Mittal Medicos?
Unlock and access historical data on people associated with Mittal Medicos, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mittal Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mittal Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
